Catalog No.
RVV03302
Species reactivity
Influenza A virus (A/mountain hawk-eagle/Kumamoto/1/07(H5N1)), Influenza A virus (A/duck/Vietnam/G12/2008(H5N1)), Influenza A virus (strain A/Puerto Rico/8/1934 H1N1), Influenza A virus (strain A/Aichi/2/1968 H3N2), Influenza A virus (strain A/Duck/Czechoslovakia/1956 H4N6), Influenza A virus (strain A/Chicken/Germany/n/1949 H10N7), Influenza A virus (A/duck/Vietnam/G32/2008(H11N9)), Influenza A virus (strain A/Duck/Alberta/60/1976 H12N5), Influenza A virus (strain A/Gull/Maryland/704/1977 H13N6), Influenza A virus (A/turkey/Wisconsin/1966(H9N2)), Influenza A virus (strain A/Turkey/Ontario/6118/1968 H8N4), Influenza A virus (A/turkey/Massachusetts/3740/1965(H6N2)), Influenza A virus (A/swan/Shimane/42/1999(H7N8)), Influenza A virus (A/whistling swan/Shimane/580/2002(H5N3)), Influenza A virus (A/swan/Shimane/42/1999(H7N8)), Influenza A virus (A/whistling swan/Shimane/580/2002(H5N3))
Host species
Human
Isotype
IgG1
Clonality
Monoclonal
Target
Nucleoprotein, Nucleocapsid protein, Protein N, NP, Influenza Virus (Flu)
Concentration
0.55 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
C9K7A3, F1T0Q9, P03466, I6TAH8, P15662, P16984, F1T0U2, D1LNF5, P15665, A8VQA1, Q20P01, Q0A474, A0JCA4, G5EJ28, A0JCA4, G5EJ28
Applications
ELISA, IF, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Comparison of whole blood on filter strips with serum for avian influenza virus antibody detection in wild birds., PMID:40491934
No Evidence of Anti-Influenza Nucleoprotein Antibodies in Retail Milk from Across Canada (April-July 2024)., PMID:40474813
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019-2020 Season in Philadelphia, Pennsylvania., PMID:40452165
M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy., PMID:40333315
Design, Synthesis and In Vivo Evaluation of a Candidate Fusion Epitopic Construct Vaccine Based on M2e, HA1, HA2, NA and NP Fragments of the Highly Pathogenic Avian H5N1 Influenza Virus., PMID:40256578
Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens., PMID:40181968
Fluorescent Microsphere Immunoassay for Isotype-Specific H5N1 Antibody Detection in Serum and Milk Samples From Dairy Cattle: A Tool for Epidemiological Surveillance., PMID:40145266
Characteristics of the First Domestic Duck-Origin H12N8 Avian Influenza Virus in China., PMID:40141383
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states., PMID:40139568
Detection of antibodies against influenza A viruses in cattle., PMID:40130892
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector., PMID:40023902
Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses., PMID:39958330
Evaluation of an N1 NA antibody-specific enzyme-linked lectin assay for detection of H5N1 highly pathogenic avian influenza virus infection in vaccinated birds., PMID:39956396
Co-Delivery of Multiple Toll-Like Receptor Agonists and Avian Influenza Hemagglutinin on Protein Nanoparticles Enhances Vaccine Immunogenicity and Efficacy., PMID:39924738
Rapid and specific on-site H5Nx avian influenza diagnosis via RPA and PAM-independent CRISPR-Cas12a assay combined with anti-NP antibody-based viral RNA purification., PMID:39896844
Immunogenicity in mice and non-human primates of an Advax-CpG55.2-adjuvanted recombinant hemagglutinin seasonal quadrivalent influenza vaccine., PMID:39798433
Impact of influenza immune imprinting on immune responses to subsequent vaccinations in mice., PMID:39731808
DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge., PMID:39692514
Construction with recombinant epitope-expressing baculovirus enhances protective effects of inactivated H9N2 vaccine against heterologous virus., PMID:39671758
Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection., PMID:39603189
Highly Pathogenic H5N1 Influenza A Virus (IAV) in Blue-Winged Teal in the Mississippi Flyway Is Following the Historic Seasonal Pattern of Low-Pathogenicity IAV in Ducks., PMID:39599570
Avian influenza virus circulation and immunity in a wild urban duck population prior to and during a highly pathogenic H5N1 outbreak., PMID:39578905
DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge., PMID:39553933
Deep mutational scanning of H5 hemagglutinin to inform influenza virus surveillance., PMID:39531474
Dissecting immunological mechanisms underlying influenza viral nucleoprotein-induced mucosal immunity against diverse viral strains., PMID:39508450
Inserting CTL Epitopes of the Viral Nucleoprotein to Improve Immunogenicity and Protective Efficacy of Recombinant Protein against Influenza A Virus., PMID:39452110
Differential detection of SARS-CoV-2 variants and influenza A viruses utilizing a dual lateral flow strip based on colloidal gold-labeled monoclonal antibodies., PMID:39341304
Detection and Monitoring of Highly Pathogenic Influenza A Virus 2.3.4.4b Outbreak in Dairy Cattle in the United States., PMID:39339851
The frequency and function of nucleoprotein-specific CD8+ T cells are critical for heterosubtypic immunity against influenza virus infection., PMID:39082839
Efficacy of commercial recombinant HVT vaccines against a North American clade 2.3.4.4b H5N1 highly pathogenic avian influenza virus in chickens., PMID:39012858
Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus., PMID:38975350
An avian-origin internal backbone effectively increases the H5 subtype avian influenza vaccine candidate yield in both chicken embryonated eggs and MDCK cells., PMID:38970848
Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose-Chitosan Nanoparticle-Based Intranasal Vaccine in Swine., PMID:38932376
Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine., PMID:38926455
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein., PMID:38805853
A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge., PMID:38805804
Assessment of CD8+ T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study., PMID:38729196
Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2., PMID:38714444
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase., PMID:38430907
The protective effect of intranasal immunization with influenza virus recombinant adenovirus vaccine on mucosal and systemic immune response., PMID:38394888
Gold Nanoparticle-Decorated Polymer Particles for High-Optical-Density Immunoassay Probes., PMID:38291580
Thiolated chitosan encapsulation constituted mucoadhesive nanovaccine confers broad protection against divergent influenza A viruses., PMID:38220319
Harnessing preexisting influenza virus-specific immunity increases antibody responses against SARS-CoV-2., PMID:38206036
A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age., PMID:38157402
Equine influenza outbreak in Eastern of Algeria in 2021: The first introduction of Florida Clade 1 to Maghreb area., PMID:38118336
Combinatorial immune refocusing within the influenza hemagglutinin RBD improves cross-neutralizing antibody responses., PMID:38096052
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib., PMID:37941436
Efficacy of inactivated and RNA particle vaccines against a North American Clade 2.3.4.4b H5 highly pathogenic avian influenza virus in chickens., PMID:37932132
Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses., PMID:37916834
Nanoparticles Carrying Conserved Regions of Influenza A Hemagglutinin, Nucleoprotein, and M2 Protein Elicit a Strong Humoral and T Cell Immune Response and Protect Animals from Infection., PMID:37764217
For research use only. Not for human or drug use.
